Timolol/bendrofluazide combination ('Prestim') in the treatment of poorly controlled hypertensive patients in general practice
A study was carried out in general practice to investigate the effectiveness and tolerance of a fixed-dose combination of timolol maleate (10 mg) and bendrofluazide (2.5 mg) in 20 hypertensive patients who had been difficult to control with previous antihypertensive therapy. Patients were started in...
| Publié dans: | Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 3(1984), 9 vom: 11., Seite 631-5 |
|---|---|
| Auteur principal: | |
| Format: | Article |
| Langue: | English |
| Publié: |
1984
|
| Accès à la collection: | Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC) |
| Sujets: | Journal Article Antihypertensive Agents Drug Combinations Bendroflumethiazide 5Q52X6ICJI prestim 74335-22-1 Timolol 817W3C6175 Prazosin |